ClinicalTrials.gg
Drug

Sodium zirconium cyclosilicate clinical trials

Also written Lokelma and ZS.

Its developmentBy AstraZeneca, step by step20 company-led studies, furthest phase 4: when each phase was reached, its deals, target and what is ahead.
studies test it
30
open now
5
in phase 3
15
first study started
2014

How each study uses sodium zirconium cyclosilicate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the sodium zirconium cyclosilicate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 May 2018 · LOKELMA · NDA 207078 (FDA, Drugs@FDA)
European Union
22 Mar 2018 · Lokelma · EMEA/H/C/004029 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Sodium Zirconium Cyclosilicate
15
Sodium Zirconium Cyclosilicate (SZC)
6
SZC
3
Sodium Zirconium Cyclosilicate (ZS) 10g
2
Sodium Zirconium Cyclosilicate (ZS) 5g
2

Brand

Lokelma
8

Development codes

ZS
2

Studies by the year they started

30 studies that test it; most in 2021 (9)

Studies that test sodium zirconium cyclosilicate, by start year
YearStudies
20143
20161
20174
20182
20202
20219
20224
20243
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
5
Phase 3
15
Phase 4
7
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 11

AstraZeneca (16) · ZS Pharma, Inc. (3) · Fundación para la Investigación del Hospital Clínico de Valencia (2) · Michael Fu (1) · St George's, University of London (1) · Alexandria University (1) · Guangdong Provincial People's Hospital (1) · Qianfoshan Hospital (1)

Often tested with

Tested in the same studies.

Polystyrene sulfonic acid (2) · Tacrolimus (1) · Cyclosporine (1) · Polyethylene glycol 3350 (1) · Patiromer (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 2 in phase 3

Studies that test sodium zirconium cyclosilicate, phase 3 first.

Studies

Open first, then newest update. How each study uses sodium zirconium cyclosilicate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 30

See all 30 studies that test sodium zirconium cyclosilicate →

What changed recently

From the registry's own updates since Oct 19, 2026.

Codes

What other systems call sodium zirconium cyclosilicate · ClinicalTrials.gg INT000213

  • MeSH (NLM) C000597310sodium zirconium cyclosilicateConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) D652ZWF066SODIUM ZIRCONIUM CYCLOSILICATEConfirmed FDA, NLM
  • RxNorm 2047628One source FDA
  • NCI Thesaurus C152381Sodium Zirconium CyclosilicateOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.